These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 6890355
1. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents. Keller HJ, Keppler B, Schmähl D. Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355 [Abstract] [Full Text] [Related]
4. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents. Keller HJ, Keppler B, Schmähl D. J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104 [No Abstract] [Full Text] [Related]
5. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes. Keppler BK, Schmähl D. Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844 [Abstract] [Full Text] [Related]
6. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra KL, Rodriguez M, Powis G. Cancer Res; 1989 Feb 15; 49(4):977-82. PubMed ID: 2912564 [Abstract] [Full Text] [Related]
7. Tumor inhibition by titanocene complexes: activity against sarcoma 180. Köpf-Maier P, Preiss F, Marx T, Klapötke T, Köpf H. Anticancer Res; 1986 Feb 15; 6(1):33-7. PubMed ID: 3954328 [Abstract] [Full Text] [Related]
11. Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Jones MM, Basinger MA. Anticancer Res; 1989 Feb 15; 9(6):1937-41. PubMed ID: 2627140 [Abstract] [Full Text] [Related]
12. [Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy]. Uhl J, Langrock K, Krieghoff B, Hambsch K. Radiobiol Radiother (Berl); 1987 Feb 15; 28(1):51-7. PubMed ID: 3588859 [No Abstract] [Full Text] [Related]
14. Antitumor activity of 1.3-diketonato zirconium (IV) and hafnium (IV) complexes. Keppler BK, Michels K. Arzneimittelforschung; 1985 Feb 15; 35(12):1837-9. PubMed ID: 4096740 [Abstract] [Full Text] [Related]
15. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats]. Karaivanova MK. Eksp Med Morfol; 1974 Feb 15; 13(4):237-42. PubMed ID: 4219353 [No Abstract] [Full Text] [Related]
16. Titanocene dichloride--the first metallocene with cancerostatic activity. Köpf H, Köpf-Maier P. Angew Chem Int Ed Engl; 1979 Jun 15; 18(6):477-8. PubMed ID: 111586 [No Abstract] [Full Text] [Related]
17. Walker carcinosarcoma 256 in study of anticancer agents. II. Results. Everett J. Cancer Res; 1966 Aug 15; 26(8 Pt 2):942-9. PubMed ID: 4224206 [No Abstract] [Full Text] [Related]
19. Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity. Rosenoer VM, Mitchley BC, Roe FJ, Connors TA. Cancer Res; 1966 Aug 15; 26(8 Pt 2):937-41. PubMed ID: 5212554 [No Abstract] [Full Text] [Related]